DWF advises Algebris Investments in €19 million investment round for Biocentis

"DWF advised Algebris Investments in a €19 million investment round in Biocentis, a pioneering life sciences company. The funding, Algebris' third completed in 2025, reinforces its strategy to back European deeptech technologies with a direct impact on CO₂ reduction."

DWF represented Algebris Investments in the €19 million investment round in Biocentis. The transaction involved a €19 million financing into Biocentis, a pioneering company in the life sciences sector. With this investment, which is Algebris Investments' third completed transaction in 2025, the investor consolidates its strategy of supporting European deeptech technologies that have a direct impact on CO₂ reduction. DWF represented Algebris Investments with a team composed by: Partner Antonio Ferri and associate Federica Boscolo.

DWF advises Algebris Investments in €19 million investment round for Biocentis

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads